ENDRA Life Sciences Inc. (NDRA)

USD 4.62

(0.87%)

Market Cap (In USD)

2.48 Million

Revenue (In USD)

-

Net Income (In USD)

-10.06 Million

Avg. Volume

3.58 Million

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
4.01-4882.5
PE
-
EPS
-
Beta Value
0.74
ISIN
US29273B3024
CUSIP
29273B104
CIK
1681682
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Mr. Alexander Y. Tokman
Employee Count
-
Website
https://www.endrainc.com
Ipo Date
2017-06-30
Details
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.